No Data
Yunnan Baiyao Group (000538.SZ): In terms of advantageous OTC channels, a nationwide service has targeted 5,000 leading chains, covering over 0.4 million stores.
On January 10, Gelonghui reported that Yunnan Baiyao Group (000538.SZ) stated during an investor research meeting that, in terms of Pharmaceuticals, the company's marketing network covers Medical Institutions and retail pharmacies across all provinces, regions, counties, and towns in the country. In the advantageous OTC channel, the company has identified services for 5,000 leading chains nationwide, covering over 400,000 stores, particularly achieving high coverage, penetration rates, and strong market control capabilities in well-developed areas such as East China, Hunan, Hubei, and Yunnan, implementing special marketing cooperation with "one province, one policy" and even "one chain, one policy". The company has also partnered with major platforms such as Alibaba, JD.com, and Douyin.
The number has reached a historical high! So far this year, 17 A-share listed companies have announced special dividend plans, including Contemporary Amperex Technology and Yunnan Baiyao Group.
① According to incomplete Statistics, as of the time of publication, 17 A-share listed companies have announced special dividend plans for 2024 this year (attached table), setting a record high for the year. Among them, the special dividend amounts of Contemporary Amperex Technology, Yunnan Baiyao Group, S.F. Holding, and others exceed 2 billion yuan. ② In addition, listed companies such as Fuhua, Three Squirrels Inc., and Chongqing Qin'an M&E PLC have announced special dividend plans before the Spring Festival.
Does This Valuation Of Yunnan Baiyao Group Co.,Ltd (SZSE:000538) Imply Investors Are Overpaying?
HAITONG INT'L: Bullish on the bottom reversal of the Traditional Chinese Medicine Industry, with the State-owned Enterprise Reform and mergers and acquisitions resonating in development.
As aging continues to intensify, the demand in the Silver economy and chronic disease medication-related fields is viewed as Bullish.
Lacklustre Performance Is Driving Yunnan Baiyao Group Co.,Ltd's (SZSE:000538) Low P/E
Express News | Yunnan Baiyao Says It Plans to Jointly Set up Fund Worth 7 Bln Yuan With Boci Investment
102884128 : getting disappointed with this counter. every day drop.